Form 4: Oscar Health Director Receives Deferred Stock Units
Statement of Changes in Beneficial Ownership
Oscar Health, Inc. reports that Director Sankaran Sid received 1,203 deferred stock units on April 9, 2026, as part of a compensation plan.
Summary
- Sankaran Sid, a Director at Oscar Health, Inc., was granted 1,203 deferred stock units on April 9, 2026.
- These units are equivalent to shares of the Issuer's Class A common stock.
- The grant was made in lieu of cash retainer payments for board service, under the company's Deferred Compensation Plan for Directors.
- The value of these units was based on the closing stock price of $14.54 on April 9, 2026.
- The deferred stock units will be settled in cash or stock within 45 days of the termination of service, a change in control, death, or disability.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation transaction for a director and does not inherently indicate positive or negative performance for the company.
Positives
- Director compensation is being structured in a way that aligns with the company's stock performance.
- The use of deferred stock units can incentivize long-term commitment from board members.
Risks
- The value of the deferred stock units is subject to the fluctuation of Oscar Health's Class A common stock price.
- Settlement of the deferred stock units is contingent on future events such as termination of service or change in control.
Future Outlook
The deferred stock units will be settled in cash or shares of Class A common stock within 45 days of specific triggering events, including termination of service, change in control, death, or disability.
Industry Context
StockSavvy.ai notes that the use of deferred stock units for director compensation is a common practice in the healthcare and technology sectors, aiming to align board interests with shareholder value and retain talent.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan | Director Sankaran Sid elected to receive deferred stock units in lieu of cash retainer payments under the Issuer's Amended and Restated Deferred Compensation Plan for Directors. | 04/09/2026 | Standard practice for director compensation, aligning incentives with company stock performance. |
Related Party Transactions
- Grant of deferred stock units to Director Sankaran Sid in lieu of cash compensation.
Stakeholder Impact
- Shareholders: The issuance of stock units could lead to dilution if settled in shares, but also aligns director compensation with stock performance.
- Employees: No direct impact mentioned.
- Management: Standard compensation practice, no immediate impact.
- Creditors: No direct impact mentioned.
Next Steps
- Settlement of deferred stock units upon occurrence of termination of service, change in control, death, or disability.
Key Dates
| Date | Description |
|---|---|
| 04/09/2026 | Transaction Date for the grant of deferred stock units. |
| 04/13/2026 | Date of filing of the Form 4. |
Keywords
Oscar Health, OSCR, Form 4, Deferred Stock Units, Director Compensation, SEC Filing, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.